Bayer continues to fight generic competition of its birth control pills
The Food and Drug Administration (FDA) may have granted permission to drug companies to market generic versions of Bayer’s blockbuster birth control pills Yasmin and Yaz, but Bayer is not giving up its fight to prevent other companies from taking a bite out its profits. The German drug company said Wednesday it will continue trying to protects its patents on its pills despite a New York judge’s dismissal of Bayer’s latest patent infringement lawsuit late Tuesday against Watson Pharmaceuticals and Sandoz.

A Virginia woman has filed a lawsuit against the makers of
Despina Papparis says her daughter Chloe is alive by “sheer luck.” The Canadian teenager, now 18, was rushed to the hospital after suffering from bad migraines and vomiting that was originally thought to be symptoms of the swine flu. But an emergency room doctor ordered a CT scan that found five blood clots in her brain. Doctors said if she had she waited one more day to seek treatment, she would have died. But it was what they said caused the malady that took the Papparises by surprise. They said her birth control pills were to blame.